Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/202639
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorMartinez-Pinna, Juan-
dc.contributor.authorMarroqui, Laura-
dc.contributor.authorHmadcha, Abdelkrim-
dc.contributor.authorLópez-Beas, Javier-
dc.contributor.authorSoriano Ubeda, Sergi-
dc.contributor.authorVillar-Pazos, Sabrina-
dc.contributor.authorAlonso-Magdalena, Paloma-
dc.contributor.authorDos Santos, Reinaldo S.-
dc.contributor.authorQuesada, Iván-
dc.contributor.authorMartín, Franz-
dc.contributor.authorSoria Escoms, Bernat-
dc.contributor.authorGustafsson, Jan-Åke-
dc.contributor.authorNadal, Ángel-
dc.date.accessioned2020-03-04T08:04:23Z-
dc.date.available2020-03-04T08:04:23Z-
dc.date.issued2019-06-27-
dc.identifierdoi: 10.1007/s00125-019-4925-y-
dc.identifiere-issn: 1432-0428-
dc.identifierissn: 0012-186X-
dc.identifier.citationDiabetologia 62: 1667-1680 (2019)-
dc.identifier.urihttp://hdl.handle.net/10261/202639-
dc.description.abstractAims/hypothesis: Bisphenol-A (BPA) is a widespread endocrine-disrupting chemical that has been associated with type 2 diabetes development. Low doses of BPA modify pancreatic beta cell function and induce insulin resistance; some of these effects are mediated via activation of oestrogen receptors α (ERα) and β (ERβ). Here we investigated whether low doses of BPA regulate the expression and function of ion channel subunits involved in beta cell function. Methods: Microarray gene profiling of isolated islets from vehicle- and BPA-treated (100 μg/kg per day for 4 days) mice was performed using Affymetrix GeneChip Mouse Genome 430.2 Array. Expression level analysis was performed using the normalisation method based on the processing algorithm ‘robust multi-array average’. Whole islets or dispersed islets from C57BL/6J or oestrogen receptor β (ERβ) knockout (Erβ) mice were treated with vehicle or BPA (1 nmol/l) for 48 h. Whole-cell patch-clamp recordings were used to measure Na and K currents. mRNA expression was evaluated by quantitative real-time PCR. Results: Microarray analysis showed that BPA modulated the expression of 1440 probe sets (1192 upregulated and 248 downregulated genes). Of these, more than 50 genes, including Scn9a, Kcnb2, Kcnma1 and Kcnip1, encoded important Na and K channel subunits. These findings were confirmed by quantitative RT-PCR in islets from C57BL/6J BPA-treated mice or whole islets treated ex vivo. Electrophysiological measurements showed a decrease in both Na and K currents in BPA-treated islets. The pharmacological profile indicated that BPA reduced currents mediated by voltage-activated K channels (K2.1/2.2 channels) and large-conductance Ca-activated K channels (K1.1 channels), which agrees with BPA’s effects on gene expression. Beta cells from ERβ mice did not present BPA-induced changes, suggesting that ERβ mediates BPA’s effects in pancreatic islets. Finally, BPA increased burst duration, reduced the amplitude of the action potential and enlarged the action potential half-width, leading to alteration in beta cell electrical activity. Conclusions/interpretation: Our data suggest that BPA modulates the expression and function of Na and K channels via ERβ in mouse pancreatic islets. Furthermore, BPA alters beta cell electrical activity. Altogether, these BPA-induced changes in beta cells might play a role in the diabetogenic action of BPA described in animal models.-
dc.description.sponsorshipThis work was supported by Ministerio de Economía y Competitividad, Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) grants BPU2017-86579-R and SAF2014-58335-P (AN) and BFU2016-77125-R (IQ); Generalitat Valenciana PROMETEO II/2015/016 (AN); Grant for Networks of Excellence from MICINN ‘Nuclear Receptors in Cancer, Metabolism and Inflammation’ (NuRCaMeIn) (SAF2017-90604-REDT); Spanish Institute of Health Carlos III grants PI16/00259 (AH), PI17/02104 and RD16/0011/0034 (BS) co-financed by FEDER Funds. LM holds a Juan de la Cierva fellowship from the Ministry of Economy, Industry and Competitiveness (IJCI-2015-24482). CIBERDEM is an initiative of the Instituto de Salud Carlos III. J-AG was supported by the Robert A. Welch Foundation (E-0004).-
dc.languageeng-
dc.publisherSpringer Nature-
dc.relationinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/BPU2017-86579-R-
dc.relationSAF2017-90604-REDT/AEI/10.13039/501100011033-
dc.relationBPU2017-86579-R/AEI/10.13039/501100011033-
dc.relationBPU2017-86579-R/AEI/10.13039/501100011033-
dc.relationinfo:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2014-58335-P-
dc.relationinfo:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/BFU2016-77125-R-
dc.relationinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/SAF2017-90604-REDT-
dc.relationSAF2017-90604-REDT/AEI/10.13039/501100011033-
dc.relationinfo:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/IJCI-2015-24482-
dc.rightsclosedAccess-
dc.subjectBeta cell-
dc.subjectDiabetes-
dc.subjectEndocrine-disrupting chemicals-
dc.subjectK+ channels-
dc.subjectNa+ channels-
dc.subjectOestrogen receptor β-
dc.subjectBisphenol-A-
dc.titleOestrogen receptor β mediates the actions of bisphenol-A on ion channel expression in mouse pancreatic beta cells-
dc.typeartículo-
dc.identifier.doi10.1007/s00125-019-4925-y-
dc.relation.publisherversionhttp://dx.doi.org/10.1007/s00125-019-4925-y-
dc.date.updated2020-03-04T08:04:24Z-
dc.contributor.funderAgencia Estatal de Investigación (España)-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.contributor.funderAgencia Estatal de Investigación (España)-
dc.contributor.funderAgencia Estatal de Investigación (España)-
dc.contributor.funderEuropean Commission-
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)-
dc.contributor.funderGeneralitat de Catalunya-
dc.contributor.funderInstituto de Salud Carlos III-
dc.contributor.funderCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (España)-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100002809es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100011033es_ES
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.openairetypeartículo-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
Aparece en las colecciones: (CABIMER) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

39
checked on 13-abr-2024

WEB OF SCIENCETM
Citations

35
checked on 26-feb-2024

Page view(s)

154
checked on 19-abr-2024

Download(s)

26
checked on 19-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.